By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950



Company News
Bellicum (BLCM) Announces Submission Of BPX-701 And BPX-601 Clinical Trial Protocols For Review By The NIH RAC 1/11/2016 11:16:34 AM
Bellicum (BLCM) To Be Added To The NASDAQ Biotechnology Index 12/15/2015 12:01:18 PM
Bellicum (BLCM) And Astellas (ALPMY) Announce License Agreement For Cancer Target PSCA In Cell And Gene Therapy 12/11/2015 10:48:44 AM
Bellicum (BLCM) Announces Oral Presentation At American Society of Hematology Showing Improved Potency And Control With CIDeCAR T-Cell Therapies 12/8/2015 12:51:16 PM
Bellicum (BLCM) Announces BPX-501 Clinical Data Demonstrating Disease-Free Outcomes In Patients With Genetic Diseases 12/7/2015 1:52:52 PM
Bellicum (BLCM) To Participate In Fireside Chat At The Piper Jaffray 27th Annual Healthcare Conference 11/24/2015 9:31:25 AM
Bellicum (BLCM) Reports Third Quarter 2015 Financial Results And Recent Program Updates 11/10/2015 11:05:45 AM
Bellicum (BLCM) Announces Data Presentations On Lead Product Candidate BPX-501 And CAR-T And TCR Pipeline Programs At The 57th American Society of Hematology Annual Meeting 11/5/2015 12:21:14 PM
Bellicum (BLCM) To Present At Two Healthcare Conferences In November 11/2/2015 9:07:52 AM
Bellicum (BLCM) Appoints Alan K. Smith As Senior Vice President Of Manufacturing 10/29/2015 11:20:58 AM